News

Technology News

MicroPhage Launches Bacterial ID Platform Study

Friday, August 21, 2009 5:02:00 AM PDT | VentureDeal Staff
Longmont, Colorado  --  Biotechnology diagnostics equipment company MicroPhage announced the launch of a new clinical trial for its bacterial identification platform.

The company says the platform was developed to more rapidly identify bacterial infections such as staph bacteria and determine antibiotic susceptibility or resistance.

Platform requires no instrumentation and contains two small reaction tubes for incubating blood culture specimens.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1